Does SIMVASTATIN Cause Lung opacity? 71 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 71 reports of Lung opacity have been filed in association with SIMVASTATIN (Simvastatin). This represents 0.3% of all adverse event reports for SIMVASTATIN.
71
Reports of Lung opacity with SIMVASTATIN
0.3%
of all SIMVASTATIN reports
39
Deaths
55
Hospitalizations
How Dangerous Is Lung opacity From SIMVASTATIN?
Of the 71 reports, 39 (54.9%) resulted in death, 55 (77.5%) required hospitalization, and 38 (53.5%) were considered life-threatening.
Is Lung opacity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIMVASTATIN. However, 71 reports have been filed with the FAERS database.
What Other Side Effects Does SIMVASTATIN Cause?
Myalgia (3,919)
Fatigue (2,066)
Arthralgia (1,775)
Drug interaction (1,744)
Nausea (1,676)
Rhabdomyolysis (1,616)
Dyspnoea (1,542)
Headache (1,470)
Drug hypersensitivity (1,433)
Muscular weakness (1,356)
What Other Drugs Cause Lung opacity?
ALBUTEROL (296)
PREDNISONE (216)
TIOTROPIUM (196)
LANSOPRAZOLE (166)
IPRATROPIUM (157)
ACETAMINOPHEN (153)
MEPOLIZUMAB (149)
PANTOPRAZOLE (140)
BUDESONIDE\FORMOTEROL (139)
MONTELUKAST (137)
Which SIMVASTATIN Alternatives Have Lower Lung opacity Risk?
SIMVASTATIN vs SINGULAIR
SIMVASTATIN vs SINTILIMAB
SIMVASTATIN vs SIPONIMOD
SIMVASTATIN vs SIPULEUCEL-T
SIMVASTATIN vs SIROLIMUS